Can a D-dimer assay, alone or combined with structured clinical risk assessment, rule out deep venous thrombosis in symptomatic patients?
Aschwanden
M
M
Department of Angiology, University Hospital, University of Basel, Petersgraben 4, CH-4031 Basel, Switzerland.
Labs
K
K
Jeanneret
C
C
Gehrig
A
A
Jaeger
K
K
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000032:analysis; D004311:Double-Blind Method; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods; D008875:Middle Aged; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D018608:Ultrasonography, Doppler / Q000379:methods*; D020246:Venous Thrombosis / Q000175:diagnosis* / Q000453:epidemiology
D015415:Biomarkers; D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D